Let Charts Inform You
Health Care: Drugs
Columbia Laboratories Inc. (CBRX: NASDAQ)
$0.82 -0.04 | -4.12%
02/09/12 - 04:00 PM ET
671.10K / 1.61M
Vol / Avg. Vol:0.84 / 0.85
Open / Prev. Close:0.82 - 0.85
Today's Range:0.64 - 4.31
52 Wk Range:-66.00%
Performance YTD:TheStreet Rating:
Portfolios with CBRX
- Portfolio NameUser Type
- UserMy Portfolio
- Contributor11 Stocks Under $4 With Upside
- Usermincronn Portfolio 1
- Usercscob Portfolio 1
- Userpharmer
- UserSUPRATRADE 2307070204
- UserSUPRATRADE VIRTUAL SKY
- Userstock fund
- UserBob700 Portfolio 1
- UserDunroamins
Latest CBRX Headlines from TheStreet
- Columbia Stock Soars (CBRX) 01.24.12 | 12:01 pm
- Columbia Stock Gaps Down On Today's Open (CBRX) 01.23.12 | 08:01 am
- Columbia Stock Gaps Up On Today's Open (CBRX) 01.18.12 | 08:01 am
- Columbia Laboratories Inc. Stock Upgraded (CBRX) 08.10.11 | 07:08 am
- 11 Stocks Under $4 With Upside: Analysts 05.11.11 | 12:05 pm
- Biotech Calendar: Key Dates for May 05.02.11 | 09:05 am
- Columbia Stock Falls On Unusually High Volume (CBRX) 04.06.11 | 02:04 pm
- 5 Pharma Stocks Trading for Under $2 12.16.10 | 12:12 pm
- Columbia Laboratories, Cardionet: Early Volume Plays 06.01.10 | 09:06 am
- Flextronics, Columbia Laboratories: Midday Volume Plays 01.28.10 | 01:01 pm
Press Releases for CBRX
- Faruqi & Faruqi, LLP Announces Investigation Of Columbia Laboratories Inc. - PR Newswire 02.09.12 | 11:02 am
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Columbia Laboratories Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2012 To Seek A Lead Plaintiff Position - Business Wire 02.02.12 | 02:02 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire 01.23.12 | 10:01 am
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By Columbia Laboratories Inc. - Business Wire 01.18.12 | 02:01 pm
- Meta-analysis Of Five Clinical Trials Including Columbia Laboratories’ PREGNANT Study Published In American Journal Of Obstetrics And Gynecology - Business Wire 12.14.11 | 06:12 am
- Columbia Laboratories Will Present November 15th At Lazard Capital Markets Healthcare Conference - Business Wire 11.14.11 | 10:11 pm
- Columbia Laboratories Reports Third Quarter 2011 Financial Results - Business Wire 11.03.11 | 06:11 am
- Columbia Laboratories To Discuss Third Quarter 2011 Financial Results On November 3, 2011, Conference Call - Business Wire 10.27.11 | 06:10 am
- Columbia Laboratories Recognized On The Deloitte Technology Fast 500 - Business Wire 10.19.11 | 04:10 pm
- Dr. Roberto Romero, NIH Principal Investigator Of PREGNANT Study, Co-Sponsored By Columbia Laboratories, Honored With John Dingell Hero For Babies Award By March Of Dimes - Business Wire 10.18.11 | 06:10 am
Partner Headlines for CBRX
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Market Losers - Benzinga 01.23.12 | 01:01 pm
- Columbia Labs Plummet after Recommendation Denial by FDA - Benzinga 01.23.12 | 09:01 am
- FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - Benzinga 01.20.12 | 04:01 pm
- Watson Pharma and Columbia Labs Plunge on Proposed FDA Review - Benzinga 01.17.12 | 01:01 pm
- Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - Benzinga 11.10.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 09.16.11 | 09:09 am
- Watson to Market Antares' OAB Drug - Analyst Blog - Zacks 07.12.11 | 10:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- Watson-Columbia Drug's NDA Accepted - Analyst Blog - Zacks 06.29.11 | 10:06 am
